626 related articles for article (PubMed ID: 9166453)
21. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
22. [Radiosensitization of Lewis lung tumor by perfluorochemical emulsion comparison between single and fractionated irradiation].
Hishikawa-itoh Y; Miyata N
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):781-7. PubMed ID: 2142500
[TBL] [Abstract][Full Text] [Related]
23. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy.
Griffin RJ; Williams BW; Park HJ; Song CW
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1516-22. PubMed ID: 15817358
[TBL] [Abstract][Full Text] [Related]
24. Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy.
Teicher BA; Holden SA; Ara G; Dupuis NP; Liu F; Yuan J; Ikebe M; Kakeji Y
Int J Cancer; 1995 May; 61(5):732-7. PubMed ID: 7768649
[TBL] [Abstract][Full Text] [Related]
25. Radiosensitization of hypoxic tumor cells by dodecafluoropentane: a gas-phase perfluorochemical emulsion.
Koch CJ; Oprysko PR; Shuman AL; Jenkins WT; Brandt G; Evans SM
Cancer Res; 2002 Jul; 62(13):3626-9. PubMed ID: 12097264
[TBL] [Abstract][Full Text] [Related]
26. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
Moulder JE; Fish BL
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1193-6. PubMed ID: 3141322
[TBL] [Abstract][Full Text] [Related]
27. Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
Teicher BA; Holden SA; Rose CM
J Natl Cancer Inst; 1985 Dec; 75(6):1129-33. PubMed ID: 3934448
[TBL] [Abstract][Full Text] [Related]
28. Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide.
Brizel DM; Hage WD; Dodge RK; Munley MT; Piantadosi CA; Dewhirst MW
Radiat Res; 1997 Jun; 147(6):715-20. PubMed ID: 9189170
[TBL] [Abstract][Full Text] [Related]
29. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
Horsman MR; Overgaard J
Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
[TBL] [Abstract][Full Text] [Related]
30. Potentiation of rat brain tumor therapy by fluosol and carbogen.
Martin DF; Kimler BF; Evans RG; Morantz RA; Vats TS
NCI Monogr; 1988; (6):119-22. PubMed ID: 3127732
[TBL] [Abstract][Full Text] [Related]
31. [Minimal effective dose of perfluorochemical emulsion as a radiosensitizer].
Hishikawa-Itoh Y; Kato T; Niwa T; Ayakawa Y; Miyata N
Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1243-8. PubMed ID: 2794648
[TBL] [Abstract][Full Text] [Related]
32. Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents.
Teicher BA; Holden SA
Cancer Treat Rep; 1987 Feb; 71(2):173-7. PubMed ID: 3100035
[TBL] [Abstract][Full Text] [Related]
33. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
Song CW; Lee I; Hasegawa T; Rhee JG; Levitt SH
Cancer Res; 1987 Jan; 47(2):442-6. PubMed ID: 3098409
[TBL] [Abstract][Full Text] [Related]
34. Tumor-dependent kinetics of partial pressure of oxygen fluctuations during air and oxygen breathing.
Cárdenas-Navia LI; Yu D; Braun RD; Brizel DM; Secomb TW; Dewhirst MW
Cancer Res; 2004 Sep; 64(17):6010-7. PubMed ID: 15342381
[TBL] [Abstract][Full Text] [Related]
35. Oxygenation of human tumor xenografts in nude mice by a perfluorochemical emulsion and carbogen breathing.
Teicher BA; Schwartz GN; Dupuis NP; Kusomoto T; Liu M; Liu F; Northey D
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1369-75. PubMed ID: 7849946
[TBL] [Abstract][Full Text] [Related]
36. Tumor oxygenation after mild-temperature hyperthermia in combination with carbogen breathing: dependence on heat dose and tumor type.
Okajima K; Griffin RJ; Iwata K; Shakil A; Song CW
Radiat Res; 1998 Mar; 149(3):294-9. PubMed ID: 9496893
[TBL] [Abstract][Full Text] [Related]
37. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
Rockwell S; Mate TP; Irvin CG; Nierenburg M
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416
[TBL] [Abstract][Full Text] [Related]
38. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors.
Rodrigues LM; Howe FA; Griffiths JR; Robinson SP
J Magn Reson Imaging; 2004 Apr; 19(4):482-8. PubMed ID: 15065173
[TBL] [Abstract][Full Text] [Related]
39. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
Holden SA; Teicher BA; McIntosh NL; Rose CM
Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174
[TBL] [Abstract][Full Text] [Related]
40. Tumour oxygenation, radiosensitivity, and necrosis before and/or after nicotinamide, carbogen and perflubron emulsion administration.
Thomas CD; Prade M; Guichard M
Int J Radiat Biol; 1995 May; 67(5):597-605. PubMed ID: 7775835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
